# Oppenheimer Holdings Inc: financial statements, quarterly

OPY · NYSE · CIK 791963 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/opy.md) · [Financials](/companies/opy/financials.md) · [Filings](/companies/opy/filings.md) · [Insiders](/companies/opy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/opy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [275](/filings/0000791963-24-000051.md) | [260 d](/filings/0000791963-25-000010.md) | [303](/filings/0000791963-25-000022.md) | [284](/filings/0000791963-25-000037.md) | [317](/filings/0001628280-25-047684.md) | [326 d](/filings/0001628280-26-012313.md) | [324](/filings/0001628280-26-029113.md) | [313](/filings/0001628280-26-051238.md) | [370](/filings/0001628280-25-047684.md) | [416 d](/filings/0001628280-26-012313.md) | [399](/filings/0001628280-26-029113.md) | [389](/filings/0001628280-26-051238.md) |
| Operating income | $m | [21.6](/filings/0000791963-24-000051.md) | [17.8 d](/filings/0001628280-26-012313.md) | [37.5](/filings/0000791963-25-000022.md) | [15.9](/filings/0000791963-25-000037.md) | [35.4](/filings/0001628280-25-047684.md) | [17.1 d](/filings/0001628280-26-012313.md) | [41.4](/filings/0001628280-26-029113.md) | [32.2](/filings/0001628280-26-051238.md) | [31.6](/filings/0001628280-25-047684.md) | [106 d](/filings/0001628280-26-012313.md) | [(27.0)](/filings/0001628280-26-029113.md) | [39.4](/filings/0001628280-26-051238.md) |
| Interest expense | $m | [19.7](/filings/0000791963-23-000042.md) | [18.2 d](/filings/0000791963-24-000015.md) | [20.5](/filings/0000791963-24-000026.md) | [22.0](/filings/0000791963-24-000042.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.8](/filings/0000791963-24-000051.md) | [6.2 d](/filings/0001628280-26-012313.md) | [11.7](/filings/0000791963-25-000022.md) | [5.6](/filings/0000791963-25-000037.md) | [10.9](/filings/0001628280-25-047684.md) | [6.3 d](/filings/0001628280-26-012313.md) | [10.7](/filings/0001628280-26-029113.md) | [10.5](/filings/0001628280-26-051238.md) | [9.9](/filings/0001628280-25-047684.md) | [32.1 d](/filings/0001628280-26-012313.md) | [(6.4)](/filings/0001628280-26-029113.md) | [12.1](/filings/0001628280-26-051238.md) |
| Net income | $m | [13.9](/filings/0000791963-24-000051.md) | [11.1 d](/filings/0001628280-26-012313.md) | [26.1](/filings/0000791963-25-000022.md) | [10.3](/filings/0000791963-25-000037.md) | [24.5](/filings/0001628280-25-047684.md) | [10.7 d](/filings/0001628280-26-012313.md) | [30.7](/filings/0001628280-26-029113.md) | [21.7](/filings/0001628280-26-051238.md) | [21.7](/filings/0001628280-25-047684.md) | [74.4 d](/filings/0001628280-26-012313.md) | [(20.6)](/filings/0001628280-26-029113.md) | [27.4](/filings/0001628280-26-051238.md) |
| Diluted EPS | $ per share | [1.21](/filings/0000791963-24-000051.md) | not reported | [2.37](/filings/0000791963-25-000022.md) | [0.92](/filings/0000791963-25-000037.md) | [2.16](/filings/0001628280-25-047684.md) | not reported | [2.72](/filings/0001628280-26-029113.md) | [1.91](/filings/0001628280-26-051238.md) | [1.90](/filings/0001628280-25-047684.md) | not reported | [(1.93)](/filings/0001628280-26-029113.md) | [2.38](/filings/0001628280-26-051238.md) |
| Basic EPS | $ per share | [1.32](/filings/0000791963-24-000051.md) | not reported | [2.50](/filings/0000791963-25-000022.md) | [0.99](/filings/0000791963-25-000037.md) | [2.38](/filings/0001628280-25-047684.md) | not reported | [2.93](/filings/0001628280-26-029113.md) | [2.06](/filings/0001628280-26-051238.md) | [2.06](/filings/0001628280-25-047684.md) | not reported | [(1.93)](/filings/0001628280-26-029113.md) | [2.55](/filings/0001628280-26-051238.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [30.8](/filings/0000791963-24-000051.md) | [28.8](/filings/0001628280-26-012313.md) | [27.7](/filings/0000791963-25-000022.md) | [33.2](/filings/0000791963-25-000037.md) | [32.2](/filings/0001628280-25-047684.md) | [33.2](/filings/0001628280-26-012313.md) | [36.7](/filings/0001628280-26-029113.md) | [37.6](/filings/0000791963-25-000037.md) | [38.3](/filings/0001628280-25-047684.md) | [38.4](/filings/0001628280-26-051238.md) | [34.6](/filings/0001628280-26-029113.md) | [38.5](/filings/0001628280-26-051238.md) |
| Total assets | $m | [2,975](/filings/0000791963-23-000042.md) | [2,875](/filings/0000791963-25-000010.md) | [3,252](/filings/0000791963-24-000026.md) | [3,263](/filings/0000791963-24-000042.md) | [3,367](/filings/0000791963-24-000051.md) | [3,383](/filings/0001628280-26-012313.md) | [3,572](/filings/0000791963-25-000022.md) | [3,687](/filings/0000791963-25-000037.md) | [3,818](/filings/0001628280-25-047684.md) | [3,722](/filings/0001628280-26-051238.md) | [3,815](/filings/0001628280-26-029113.md) | [4,231](/filings/0001628280-26-051238.md) |
| Total liabilities | $m | [2,170](/filings/0000791963-23-000042.md) | [2,086](/filings/0000791963-25-000010.md) | [2,450](/filings/0000791963-24-000026.md) | [2,450](/filings/0000791963-24-000042.md) | [2,529](/filings/0000791963-24-000051.md) | [2,532](/filings/0001628280-26-012313.md) | [2,700](/filings/0000791963-25-000022.md) | [2,790](/filings/0000791963-25-000037.md) | [2,898](/filings/0001628280-25-047684.md) | [2,725](/filings/0001628280-26-051238.md) | [2,850](/filings/0001628280-26-029113.md) | [3,234](/filings/0001628280-26-051238.md) |
| Long-term debt | $m | [113](/filings/0000791963-23-000042.md) | [113](/filings/0000791963-25-000010.md) | [113](/filings/0000791963-24-000026.md) | [113](/filings/0000791963-24-000042.md) | [113](/filings/0000791963-24-000051.md) | [0.0](/filings/0000791963-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [779](/filings/0000791963-23-000042.md) | [789](/filings/0000791963-25-000010.md) | [802](/filings/0000791963-24-000026.md) | [812](/filings/0000791963-24-000042.md) | [838](/filings/0000791963-24-000051.md) | [850](/filings/0001628280-26-012313.md) | [872](/filings/0000791963-25-000022.md) | [897](/filings/0000791963-25-000037.md) | [920](/filings/0001628280-25-047684.md) | [984](/filings/0001628280-26-051238.md) | [952](/filings/0001628280-26-029113.md) | [983](/filings/0001628280-26-051238.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [66.6 d](/filings/0000791963-24-000051.md) | [65.4 d](/filings/0001628280-26-012313.md) | [(79.0)](/filings/0000791963-25-000022.md) | [(115) d](/filings/0000791963-25-000037.md) | [11.4 d](/filings/0001628280-25-047684.md) | [74.7 d](/filings/0001628280-26-012313.md) | [(91.7)](/filings/0001628280-26-029113.md) | [40.1 d](/filings/0001628280-26-051238.md) | [63.4 d](/filings/0001628280-25-047684.md) | [177 d](/filings/0001628280-26-012313.md) | [(190)](/filings/0001628280-26-029113.md) | [(55.0) d](/filings/0001628280-26-051238.md) |
| Capital expenditure | $m | [2.7 d](/filings/0000791963-24-000051.md) | [4.6 d](/filings/0001628280-26-012313.md) | [0.3](/filings/0000791963-25-000022.md) | [1.4 d](/filings/0000791963-25-000037.md) | [0.2 d](/filings/0001628280-25-047684.md) | [3.3 d](/filings/0001628280-26-012313.md) | [1.7](/filings/0001628280-26-029113.md) | [1.1 d](/filings/0001628280-26-051238.md) | [1.2 d](/filings/0001628280-25-047684.md) | [1.2 d](/filings/0001628280-26-012313.md) | [0.0](/filings/0001628280-26-029113.md) | [2.0 d](/filings/0001628280-26-051238.md) |
| Dividends paid | $m | [1.6 d](/filings/0000791963-24-000051.md) | [1.5 d](/filings/0001628280-26-012313.md) | [1.6](/filings/0000791963-25-000022.md) | [1.5 d](/filings/0000791963-25-000037.md) | [1.9 d](/filings/0001628280-25-047684.md) | [1.9 d](/filings/0001628280-26-012313.md) | [1.9](/filings/0001628280-26-029113.md) | [1.9 d](/filings/0001628280-26-051238.md) | [1.9 d](/filings/0001628280-25-047684.md) | [1.9 d](/filings/0001628280-26-012313.md) | [12.4](/filings/0001628280-26-029113.md) | [2.1 d](/filings/0001628280-26-051238.md) |
| Share repurchases | $m | [24.0 d](/filings/0000791963-24-000051.md) | [3.9 d](/filings/0001628280-26-012313.md) | [8.4](/filings/0000791963-25-000022.md) | [0.9 d](/filings/0000791963-25-000037.md) | [0.3 d](/filings/0001628280-25-047684.md) | [0.0 d](/filings/0001628280-26-012313.md) | [0.1](/filings/0001628280-26-029113.md) | [0.6 d](/filings/0001628280-26-051238.md) | [0.0 d](/filings/0001628280-25-047684.md) | [2.3 d](/filings/0001628280-26-012313.md) | [0.0](/filings/0001628280-26-029113.md) | [0.0 d](/filings/0001628280-26-051238.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.2](/filings/0000791963-23-000042.md) | [12.0](/filings/0000791963-24-000026.md) | [11.0](/filings/0000791963-24-000042.md) | [11.4](/filings/0000791963-24-000051.md) | [11.0](/filings/0000791963-25-000022.md) | [11.1](/filings/0000791963-25-000037.md) | [11.3](/filings/0001628280-25-047684.md) | [11.3](/filings/0001628280-26-029113.md) | [11.3](/filings/0001628280-26-051238.md) | [11.5](/filings/0001628280-25-047684.md) | [10.6](/filings/0001628280-26-029113.md) | [11.5](/filings/0001628280-26-051238.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.